Johannes Schwerk

6PUBLICATIONS
38CO-AUTHORS
Innate immunityHaematological tumoursMicro- and nanosystemsVirology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 23, 2022
Type I Interferon Signaling Controls Gammaherpesvirus Latency In Vivo.

Johannes Schwerk, Lucas Kemper, Kendra A Bussey

|Aug 03, 2021
Endomembrane targeting of human OAS1 p46 augments antiviral activity.

Frank W Soveg, Johannes Schwerk, Nandan S Gokhale

|Nov 20, 2019
RNA-binding protein isoforms ZAP-S and ZAP-L have distinct antiviral and immune resolution functions.

Johannes Schwerk, Frank W Soveg, Andrew P Ryan

|Sep 20, 2017
IFN-λ 'guts' neutrophil-mediated inflammation.

Emily A Hemann, Johannes Schwerk, Ram Savan

|Nov 02, 2016
Interferon lambda 4 expression is suppressed by the host during viral infection.

MeeAe Hong, Johannes Schwerk, Chrissie Lim

Pageof 1